semaglutide cardiovascular outcomes news 2025 october 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants #VisualAbstract: Semaglutide and Cardiovascular Outcomes

Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial

This research was financially supported by Ningxia Natural Science Foundation (grant no

mild nausea may occur Weeks 5-8: Increase to 0.5 mg

NICE guidance (CG189 and updates) also supports consideration of surgery at a BMI of 3034.9 kg/m in adults with recent-onset type 2 diabetes, and recommends lower BMI thresholds for some minority ethnic groups

28 Orforglipron demonstrated over 12% weight loss in a 72-week Phase III study, positioning it as a potent alternative to weekly injections

Haplopine ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice and Tnf-A/Ifn--induced inflammation in human keratinocyte